Date |
Topic |
Speaker |
08/07/2020 |
Clinical Trials |
Gary Cutter, University of Alabama at Birmingham |
08/21/2020 |
Neurosarcoidosis / CNS Vasculitis / NP-SLE / Neuro-Behcet's |
Jeffrey Gelfand, University of California, San Francisco |
09/04/2020 |
Lab Techniques & Tools for Understanding Ab-mediated Diseases |
Andrew McKeon, Mayo Clinic |
09/18/2020 |
Autoimmune Myelitis and its Mimics |
Eoin Flanagan, Mayo Clinic |
10/02/2020 |
B Cell and Autoantibody-mediated Pathogenesis in CNS Autoimmunity |
Jeffrey Bennett, University of Colorado |
10/16/2020 |
Caring for Advanced MS |
Francois Bethoux, Cleveland Clinic |
11/06/2020 |
PML and Opportunistic Infections |
Joe Berger, University of Pennsylvania |
11/20/2020 |
Basic Science of Remyelination |
Wendy Macklin, University of Colorado |
12/04/2020 |
Advanced MRI Techniques [for MS/Neuroinflammation] |
Daniel Ontaneda, Cleveland Clinic |
12/18/2020 |
Anti-NMDA Receptor Encephalitis and Mechanisms of Disease |
Josep Dalmau, University of Barcelona, University of Pennsylvania |
New Year’s Day – January 1, 2021 |
01/15/2021 |
Hematopoietic and Mesenchymal Stem Cell Therapy for MS |
Jeffrey Cohen, Cleveland Clinic |
02/05/2021 |
Progressive MS: Challenges in Finding and Demonstrating Effective Therapies |
Robert Fox, Cleveland Clinic |
02/19/2021 |
Pediatric MS |
Brenda Banwell, Children’s Hospital of Philadelphia |
ACTRIMS Forum 2021 – February 25-27, 2021 |
03/05/2021 |
Emerging Autoimmune Diseases |
Stacy Clardy, University of Utah |
03/19/2021 |
Immuno-Biology of MS |
Anne Cross, Washington University |
04/02/2021 |
Integrative Medicine and Cannabis |
Allen Bowling, NeuroHealth Institute, University of Colorado |
AAN Annual Meeting – April 17-23, 2021 |
05/07/2021 |
Ethnicity & Diversity in the MS Experience |
Lilyana Amezcua, University of Southern California |
CMSC Annual Meeting – June 2-5, 2021 |
06/18/2021 |
Urological Issues and Their Management in MS |
Nina Davis, Oregon Health and Science University |